Globe Life Inc. $GL Shares Sold by Carmignac Gestion

Carmignac Gestion lowered its position in Globe Life Inc. (NYSE:GL) by 35.8% in the first quarter, HoldingsChannel reports. The firm owned 170,000 shares of the company’s stock after selling 95,000 shares during the period. Carmignac Gestion’s holdings in Globe Life were worth $23,659,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of GL. Vanguard Group Inc. raised its stake in Globe Life by 0.9% during the fourth quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock worth $1,411,311,000 after purchasing an additional 86,349 shares during the period. Invesco Ltd. increased its holdings in shares of Globe Life by 2.7% during the 4th quarter. Invesco Ltd. now owns 3,948,676 shares of the company’s stock worth $552,262,000 after buying an additional 102,445 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Globe Life by 10.2% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,353,192 shares of the company’s stock worth $327,479,000 after buying an additional 217,331 shares during the last quarter. Morgan Stanley raised its position in shares of Globe Life by 7.2% during the 4th quarter. Morgan Stanley now owns 1,860,257 shares of the company’s stock valued at $260,176,000 after buying an additional 125,567 shares during the period. Finally, Arrowstreet Capital Limited Partnership raised its position in shares of Globe Life by 32.9% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,435,247 shares of the company’s stock valued at $200,734,000 after buying an additional 355,399 shares during the period. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on GL shares. Weiss Ratings cut Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday, July 20th. Jefferies Financial Group raised their target price on Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research note on Friday, July 10th. Piper Sandler lifted their target price on Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research report on Wednesday, July 15th. Morgan Stanley upped their price target on Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a research note on Monday, July 6th. Finally, JPMorgan Chase & Co. increased their price target on Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a report on Tuesday, July 21st. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, Globe Life presently has an average rating of “Moderate Buy” and a consensus price target of $191.67.

Globe Life Price Performance

Globe Life stock opened at $182.14 on Monday. The company’s 50 day simple moving average is $171.52 and its 200-day simple moving average is $154.34. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07. Globe Life Inc. has a 1 year low of $127.85 and a 1 year high of $191.55. The company has a market capitalization of $14.14 billion, a price-to-earnings ratio of 12.09 and a beta of 0.48.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). Globe Life had a return on equity of 20.73% and a net margin of 19.58%.The company had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same period in the previous year, the business posted $3.05 EPS. The business’s revenue for the quarter was up 8.0% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. As a group, equities research analysts expect that Globe Life Inc. will post 15.7 earnings per share for the current year.

Insider Transactions at Globe Life

In other Globe Life news, CFO Thomas Peter Kalmbach sold 25,650 shares of the company’s stock in a transaction on Tuesday, July 28th. The stock was sold at an average price of $178.58, for a total transaction of $4,580,577.00. Following the transaction, the chief financial officer directly owned 50,568 shares in the company, valued at $9,030,433.44. This represents a 33.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Frank M. Svoboda sold 20,000 shares of the firm’s stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $156.68, for a total value of $3,133,600.00. Following the transaction, the chief executive officer owned 54,020 shares of the company’s stock, valued at approximately $8,463,853.60. This represents a 27.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 169,174 shares of company stock valued at $28,553,849 over the last three months. 2.11% of the stock is currently owned by company insiders.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.